Clinical Trial Update: Clinical Study of 18F-FAPI-RGD in Ovarian Cancer

View source ↗

Summary

This document reports that an observational clinical study evaluating the imaging tracer 18F-FAPI-RGD in ovarian cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• 18F-FAPI-RGD (18F-FAPI-RGD)

Snippet

Sponsor: Sichuan Provincial People's Hospital | Conditions: Observational | Status: COMPLETED